ManagedCareCGM

• There are more than 30 million Americans with diabetes at an estimated cost of >$327 billion per year
• The cost to treat the complications of diabetes alone total $44.1 billion per year
• Patients with type 1 diabetes (T1D) report an average of up to 3 episodes of severe hypoglycemia per year (episodes requiring the assistance of another person).
• Studies using continuous glucose monitoring (CGM) show much more frequent episodes of clinically important hypoglycemia (<54 mg/dL), ranging from every 2-4 days to every 6 days.
• Based on previous cost estimates for hypoglycemia, nearly 100,000 ED visits and 30,000 hospitalizations annually, more than $600 million was spent on drug-related hypoglycemia during a 5-year period (2007-2011).
• CGM represents a new paradigm of care in diabetes, allowing for more precise and accurate management, with demonstrated reductions in A1C and time spent in hypoglycemia
• CGM is recommended by the American Diabetes Association (ADA) and other endocrinology-related professional societies in appropriate clinical scenarios for both type 1 and type 2 diabetes but is vastly underutilized

CGM Quick Facts References:

2018 Drug Trend Report. Express Scripts website: https://www.express-scripts.com/corporate/drug-trend-report.

Standards of medical care in diabetes—2013. Diabetes Care. 2013;36 Suppl 1:S11-66.

Pedersen-Bjergaard U, Thorsteinsson B. Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls. Curr Diab Rep. 2017; 17:131.

Geller KI,  Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, & Budnitz DS. (2014). National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med, 174(5):678-686.

Riddlesworth T, Price D, Cohen N, Beck RW. Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections. Diabetes Ther. 2017; 8:947.

ADA Standards of Medical Care in Diabetes- 2019.